Client Background
A leading global Contract Research Organization, providing end-to-end regulatory, clinical, and compliance services to pharmaceutical, biotechnology, and medical device companies. The organization operates in a highly complex, quality-driven environment, supporting diverse programs across the life sciences value chain.
Client Need
The client faced several key challenges in pharmacovigilance data exchange and compliance:
Inconsistent Data Exchange: Discrepancies between the Sponsor’s Oracle Argus system and the CROs submission systems led to missing or inaccurate regulatory data
Manual, Inefficient Reconciliation: Mismatches took weeks of correction, relying on error-prone, manual processes with limited traceability
Regulatory Compliance Risk: Late submissions increased exposure to FDA penalties worth millions, creating financial and operational threats
Limited Scalability: Huge data volumes led to expensive manual process, requiring an automated solution for accuracy, efficiency, and compliance
Solution
Innova Solutions designed and implemented an automated reconciliation solution tailored to the Sponsor–CRO safety data exchange workflow. By combining pharmacovigilance domain expertise with rule-driven automation, the team accelerated discrepancy resolution, strengthened compliance, and reduced operational risk across the case lifecycle.
Key solution components included:
Automated Discrepancy Detection: Built an automation layer to continuously detect and reconcile mismatches between the Sponsor’s Oracle Argus system and the CROs submission systems, ensuring data consistency and completeness
Accelerated Reconciliation Cycles: Compressed reconciliation timelines from weeks to hours, enabling timely follow-up submissions and more reliable regulatory reporting
Regulatory Compliance Safeguards: Automated checks and exception handling to prevent missed submissions and maintain adherence to stringent regulatory timelines
Realized Benefits
With an optimized and automated business process coupled with human-in-the-loop approach, the client achieved:
45% gain in operational efficiency, with automated workflows running faster and scaling on demand
>4M USD in annual cost savings, as SMEs focus shifted to higher-value, strategic initiatives
Prevented multi-million dollars in FDA fines and brand damage through timely, and accurate follow-up submissions
Trending Success Stories
Ready to Innovate with Us?
Let’s Talk!
Connect with us on social media
Write to us at
[email protected]